Antiparasitic Drug Repurposing Research for Alzheimer's Disease

Research into antiparasitic drug repurposing research approaches for Alzheimer's Disease. AI-powered analysis of mechanisms, evidence, and clinical status.

About Antiparasitic Drug Repurposing Research

Investigation into repurposing antiparasitic drugs for cancer and neurological conditions. AI agents analyze fenbendazole, ivermectin, and mebendazole mechanisms and clinical evidence.

About Alzheimer's Disease

2026 Alzheimer's breakthroughs: at-home Leqembi, pill-based therapies in trials, brain stimulation devices. AI-analyzed with safety scores and PubMed citations.

Standard of Care: Lecanemab (Leqembi), Donanemab — anti-amyloid antibodies. Cholinesterase inhibitors (donepezil, rivastigmine) for symptom management.